EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia

Rima S Zahr iD, Guolian Kang, Xu Zhang iD, Sara R Rashkin iD, Csaba P Kovesdy iD, Clifford Takemoto, Mitch Weiss iD, Jeffrey Lebensburger, Kenneth I Ataga iD, Santosh L Saraf iD

American Journal of Hematology · 2025

DOI: 10.1002/ajh.27678 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Rima S Zahr und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Nephrology and Hypertension, UTHSC, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Albuminuria, Anemia, Sickle Cell, Multifactorial Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albuminuria is associated with high‐risk apolipoprotein‐L1 variants ( APOL1 G1/G2) in patients with sickle cell anemia (SCA). However, this gene variant does not account for all chronic kidney disease (CKD) risk. We hypothesized that we could develop a polygenic risk score (PRS) for CKD in SCA, combining APOL1 G1/G2 with other candidate genes that modify SCA severity and further stratify patients into risk categories based on this risk score. Variants in APOL1 , HMOX1 (rs743811), BCL11A (rs1424407), and α‐thalassemia ( α −3.7 ) were identified in children with SCA enrolled in the Sickle Cell Clinical Research and Intervention Program longitudinal cohort (SCCRIP). We individually tested the association of these variants with persistent albuminuria, tested a three‐variant PRS (PRS‐3) ( APOL1 , BCL11A (rs1424407), and α −3.7 ), and developed a four‐variant PRS (PRS‐4) after adding HMOX1 (rs743811) to PRS‐3 using the summation of high‐risk alleles. An adult SCA cohort from the University of Illinois, Chicago (UIC), was used for validation. Persistent albuminuria was defined as having a urine albumin‐to‐creatinine ratio (UACR) ≥ 30 mg/g on at least 2 of 3 consecutive measurements. In both cohorts, APOL1 risk variants increased the risk while α‐thalassemia protected against persistent albuminuria. PRS‐4 was significantly associated with persistent albuminuria (SCCRIP: p = 0.004; UIC: p = 0.00016). When stratifying patients into three and four risk categories based on the PRS, 58% and 86% of the high‐risk (PRS‐3) and 54% and 89% of very high‐risk (PRS‐4) categories developed persistent albuminuria cases in the SCCRIP and UIC cohorts, respectively. A PRS may identify high‐risk SCA patients for albuminuria. Applying this PRS to guide the early implementation of disease modifiers and renoprotective therapies may help reduce the burden of SCA‐related CKD. Trial Registration: NCT02098863

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuminuriaAnemia, Sickle CellMultifactorial InheritanceAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultAllelesalpha-ThalassemiaApolipoprotein L1Cation Transport ProteinsGenetic Risk ScoreHeme Oxygenase-1Longitudinal StudiesRenal Insufficiency, ChronicRepressor ProteinsRisk Factors

Stichwörter der Autor:innen

CKDalbuminuriagenetic risk scoresickle cell anemia

Substanzen

APOL1 protein, humanApolipoprotein L1BCL11A protein, humanCation Transport ProteinsHeme Oxygenase-1HMOX1 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Paediatric Nephrology and Hypertension, UTHSC, Memphis, Tennessee, USA.
  • Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Haematology and Oncology, Sickle Cell Center, UIC, Chicago, Illinois, USA.
  • Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Nephrology, UTHSC, Memphis, Tennessee, USA.
  • Department of Hematology, UAB, Birmingham, Alabama, USA.

ORCID-Profile: Rima S Zahr, Xu Zhang, Sara R Rashkin, Csaba P Kovesdy, Mitch Weiss, Kenneth I Ataga, Santosh L Saraf

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Zahr, R. S., Kang, G., Zhang, X., Rashkin, S. R., Kovesdy, C. P., Takemoto, C., Weiss, M., Lebensburger, J., Ataga, K. I., & Saraf, S. L. (2025). Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27678

Vancouver

Zahr RS, Kang G, Zhang X, Rashkin SR, Kovesdy CP, Takemoto C, et al. Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia. American Journal of Hematology. 2025. doi:10.1002/ajh.27678

BibTeX
@article{Zahr2025,
  author = {Zahr, Rima S and Kang, Guolian and Zhang, Xu and Rashkin, Sara R and Kovesdy, Csaba P and Takemoto, Clifford and Weiss, Mitch and Lebensburger, Jeffrey and Ataga, Kenneth I and Saraf, Santosh L},
  title = {Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.27678}
}
Kostenlos starten →